Laura Chico
Stock Analyst at Wedbush
(4.79)
# 569
Out of 5,134 analysts
665
Total ratings
51.5%
Success rate
13.7%
Average return
Main Sectors:
Stocks Rated by Laura Chico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTRI Mentari Therapeutics | Initiated Coverage: Buy | $33 | $18.60 | +77.42% | 1 | Nov 13, 2026 | |
| CLYM Climb Bio | Reiterated: Buy | $25 → $27 | $10.36 | +160.62% | 9 | Nov 6, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | $53 → $51 | $45.93 | +11.04% | 25 | Nov 6, 2026 | |
| KRSA Korsana Biosciences | Reiterated: Buy | $44 | $31.65 | +39.02% | 2 | Nov 6, 2026 | |
| VERA Vera Therapeutics | Reiterated: Hold | $34 → $29 | $28.10 | +3.20% | 16 | Nov 6, 2026 | |
| BCRX BioCryst Pharmaceuticals | Reiterated: Buy | $20 → $17 | $7.61 | +123.39% | 18 | Nov 5, 2026 | |
| DNTH Dianthus Therapeutics | Reiterated: Buy | $122 | $91.81 | +32.88% | 17 | Nov 5, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $16 → $15 | $6.84 | +119.30% | 9 | Nov 5, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | $41 → $42 | $30.87 | +36.05% | 75 | Nov 5, 2026 | |
| ARDX Ardelyx | Reiterated: Buy | $9 → $8 | $3.09 | +158.90% | 22 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $24 | $18.74 | +28.07% | 28 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 → $22 | $16.08 | +36.82% | 59 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $194 → $186 | $167.40 | +11.11% | 26 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 | $50.65 | +50.05% | 37 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $212 → $225 | $253.40 | -11.21% | 71 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $2.54 | +175.59% | 14 | Oct 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $34.33 | +39.82% | 8 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $55 | $40.48 | +35.87% | 20 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $6 | $3.33 | +80.18% | 5 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $50 | $33.36 | +49.88% | 9 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 | $10.97 | +629.26% | 8 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $16.14 | +191.20% | 12 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $11 | $3.02 | +264.24% | 9 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $166 → $162 | $328.13 | -50.63% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $24 | $29.54 | -18.75% | 10 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4 | $4.36 | -8.26% | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $26.68 | +42.43% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $9.62 | +315.80% | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $7 | $1.73 | n/a | 10 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $11 | $15.72 | n/a | 4 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $10.47 | n/a | 8 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $5 | $4.10 | n/a | 5 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $4.25 | n/a | 4 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $45 | $0.3819 | n/a | 5 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $57.23 | n/a | 15 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $538.60 | n/a | 16 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.52 | n/a | 10 | Sep 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.30 | n/a | 4 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $955.47 | n/a | 16 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $3.39 | n/a | 1 | Jan 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.1271 | n/a | 1 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $62.28 | n/a | 1 | Dec 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $1.18 | n/a | 1 | Jun 30, 2017 |
Mentari Therapeutics
Nov 13, 2026
Initiated Coverage: Buy
Price Target: $33
Current: $18.60
Upside: +77.42%
Climb Bio
Nov 6, 2026
Reiterated: Buy
Price Target: $25 → $27
Current: $10.36
Upside: +160.62%
Edgewise Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $53 → $51
Current: $45.93
Upside: +11.04%
Korsana Biosciences
Nov 6, 2026
Reiterated: Buy
Price Target: $44
Current: $31.65
Upside: +39.02%
Vera Therapeutics
Nov 6, 2026
Reiterated: Hold
Price Target: $34 → $29
Current: $28.10
Upside: +3.20%
BioCryst Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $20 → $17
Current: $7.61
Upside: +123.39%
Dianthus Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $122
Current: $91.81
Upside: +32.88%
Solid Biosciences
Nov 5, 2026
Reiterated: Buy
Price Target: $16 → $15
Current: $6.84
Upside: +119.30%
Viridian Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $41 → $42
Current: $30.87
Upside: +36.05%
Ardelyx
Nov 4, 2026
Reiterated: Buy
Price Target: $9 → $8
Current: $3.09
Upside: +158.90%
Nov 4, 2026
Reiterated: Buy
Price Target: $26 → $24
Current: $18.74
Upside: +28.07%
Nov 4, 2026
Reiterated: Hold
Price Target: $23 → $22
Current: $16.08
Upside: +36.82%
Nov 3, 2026
Reiterated: Buy
Price Target: $194 → $186
Current: $167.40
Upside: +11.11%
Nov 3, 2026
Reiterated: Buy
Price Target: $76
Current: $50.65
Upside: +50.05%
Oct 29, 2026
Reiterated: Hold
Price Target: $212 → $225
Current: $253.40
Upside: -11.21%
Oct 8, 2026
Reiterated: Buy
Price Target: $7
Current: $2.54
Upside: +175.59%
Sep 23, 2026
Reiterated: Buy
Price Target: $48
Current: $34.33
Upside: +39.82%
Sep 18, 2026
Reiterated: Buy
Price Target: $63 → $55
Current: $40.48
Upside: +35.87%
Sep 15, 2026
Reiterated: Hold
Price Target: $5 → $6
Current: $3.33
Upside: +80.18%
Sep 9, 2026
Reiterated: Buy
Price Target: $42 → $50
Current: $33.36
Upside: +49.88%
Aug 14, 2026
Reiterated: Hold
Price Target: $80
Current: $10.97
Upside: +629.26%
Aug 11, 2026
Reiterated: Buy
Price Target: $47
Current: $16.14
Upside: +191.20%
Aug 5, 2026
Reiterated: Buy
Price Target: $12 → $11
Current: $3.02
Upside: +264.24%
Jun 2, 2026
Reiterated: Sell
Price Target: $166 → $162
Current: $328.13
Upside: -50.63%
May 14, 2026
Reiterated: Hold
Price Target: $21 → $24
Current: $29.54
Upside: -18.75%
May 13, 2026
Reiterated: Buy
Price Target: $5 → $4
Current: $4.36
Upside: -8.26%
May 8, 2026
Reiterated: Buy
Price Target: $38
Current: $26.68
Upside: +42.43%
May 7, 2026
Reiterated: Buy
Price Target: $40
Current: $9.62
Upside: +315.80%
Aug 7, 2024
Reiterated: Hold
Price Target: $8 → $7
Current: $1.73
Upside: n/a
Apr 11, 2024
Reiterated: Buy
Price Target: $13 → $11
Current: $15.72
Upside: n/a
Mar 20, 2024
Reiterated: Hold
Price Target: $5
Current: $10.47
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $22 → $5
Current: $4.10
Upside: n/a
Feb 11, 2022
Reiterated: Buy
Price Target: $23
Current: $4.25
Upside: n/a
Aug 11, 2020
Reiterated: Hold
Price Target: $3 → $45
Current: $0.3819
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $57.23
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $538.60
Upside: n/a
Sep 12, 2018
Downgraded: Hold
Price Target: n/a
Current: $7.52
Upside: n/a
Aug 13, 2018
Reiterated: Hold
Price Target: n/a
Current: $1.30
Upside: n/a
Aug 8, 2018
Reiterated: Hold
Price Target: n/a
Current: $955.47
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $24
Current: $3.39
Upside: n/a
Jan 4, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.1271
Upside: n/a
Dec 7, 2017
Reiterated: Buy
Price Target: n/a
Current: $62.28
Upside: n/a
Jun 30, 2017
Reiterated: Buy
Price Target: $30
Current: $1.18
Upside: n/a